Arcturus Therapeutics

United States
Wonewoc, Wisconsin, United States, 92121

Company profile

Arcturus Therapeutics company profile

Arcturus Therapeutics is a late-stage clinical mRNA medicine company that focuses on developing novel RNA therapeutics for the treatment of various rare diseases. The company owns Unlocked Nucleic Acid (UNA) chemistry technology and a patent portfolio (32 patents, USPTO granted) that allow the targeting of any gene in the human genome. It was founded in 2013 and is headquartered in San Diego, California.

Business identity

Contact email
[email protected]
Phone number
858-900-2660
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$10M-$100M
Founded
2013-01-01, Year

Headquarters

Postal code
92121
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
9
Total equity funding
$287.4M
Last funding
Grant / $9M / 2023-09-26
Last equity funding
Post IPO Equity / $200M
Investors
3
Lead investors
3
Founders
2
Articles
237
Exited on
2017-11-16

Founders and investors

Founders

Joseph PaynePad (Padmanabh) Chivukula

Lead investors

Biomedical Advanced Research and Development Authority (BARDA)Cystic Fibrosis FoundationJapan - The Government of Japan

Investors

Biomedical Advanced Research and Development Authority (BARDA)Cystic Fibrosis FoundationJapan - The Government of Japan